封面
市場調查報告書
商品編碼
1189806

血管造影市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Angiography Devices Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

心血管疾病,包括心髒病發作和中風等心血管疾病,是過早死亡的第一大原因。

根據世界衛生組織 (WHO) 的數據,2017 年心血管疾病每年導致約 1790 萬人死亡,預計到 2030 年這一數字將增加到 2360 萬以上。 因此,心血管疾病的增加可能會推動對血管造影設備的需求,並最終導致血管造影設備市場的增長。 此外,技術的快速進步、公眾意識的提高以及對微創手術的高度偏好等其他因素也補充了市場增長。

血管造影設備市場趨勢

預計在預測期內,醫院部分將主導市場

醫院部門佔據主導地位的主要驅動因素是更高的患者容量、更好的資源可用性、多樣化的地理覆蓋範圍、配套醫療基礎設施和程序的可用性、熟練勞動力的可用性、政府資金的可負擔性。 在發達市場和新興市場,隨著心血管疾病死亡人數的增加,複雜心髒病病例的數量也在增加。 與專科診所相比,醫院因其更好的可及性和可負擔性而吸引了更多的心血管疾病患者。 由於受益於大宗採購折扣以及與製造商和供應商的貿易協議,該醫院的利潤指數也在改善。 此外,這些貿易協定將為製造商及早獲得及時升級和技術先進的產品開闢新途徑,從而提高醫院的治療能力。

北美主導著血管造影設備市場

由於微創手術的高采用率、報銷制度的加強、老年人口的增長以及醫療設備的高更換率,北美在血管造影市場佔據主導地位。 強大的醫療器械公司網絡、遍布城市和州的大量醫院以及獲得融資機會是該地區市場主導地位的主要驅動力。 此外,政府機構的大力支持促進了該地區醫療保健部門心血管疾病整體治療所需的發展。

歐洲是僅次於北美的第二大市場。 歐洲國家的很大份額歸因於心血管疾病患病率高、政府投資高、產品批准過程加快以及許多血管造影篩查程序到位而導致血管造影設備的採用率上升。

血管造影設備市場競爭分析

血管造影市場正在整合且競爭激烈。 一些全球參與者主導著市場,這主要是由於嚴格的產品審批流程和對重要技術能力的需求。 主要市場參與者包括 AngioDynamics Inc.、波士頓科學公司、佳能醫療系統公司、Cardinal Health Inc.、GE Healthcare、Medtronic PLC、Koninklijke Philips NV、Shimadzu Corporation、Siemens Healthineers AG 和 Terumo Corporation。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 調查結果
  • 調查假設
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 老齡化人口的增加和心血管疾病患病率的增加
    • 微創手術對介入血管造影的需求不斷擴大
  • 市場製約因素
    • 治療和設備成本高
    • 與血管造影程序相關的風險
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按產品分類
    • 血管造影設備
    • 消耗品
      • 導管
      • 導絲
      • 造影劑
      • 切口閉合裝置
      • 配飾
  • 按技術
    • 核磁共振
    • CT
    • X光
    • 其他技術
  • 通過使用
    • 大腦
    • 頸動脈
    • 外周血管
    • 主動脈
    • 冠狀動脈
    • 其他用途
  • 最終用戶
    • 醫院
    • 診斷中心
    • 門診手術中心
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • AngioDynamics Inc.
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Cardinal Health Inc.
    • GE Healthcare
    • Medtronic PLC
    • Koninklijke Philips NV
    • Shimadzu Corporation
    • Siemens Healthineers AG
    • Terumo Corporation

第7章 市場機會今後動向

簡介目錄
Product Code: 62804

The cardiovascular diseases which include heart attacks, strokes, and other circulatory diseases have become the leading cause of premature deaths. According to the World Health Organization, 2017, cardiovascular diseases account for nearly 17.9 million deaths per year, and this number is expected to grow to more than 23.6 million by 2030. Hence, the increasing number of cardiovascular diseases is driving the demand for angiography devices, which may ultimately result in the growth of the angiography devices market. Furthermore, other factors, such as rapid technological advances, increasing awareness of the population, and a high preference for minimally invasive procedures, are supplementing the market growth.

Angiography Devices Market Trends

The Hospital Segment is Expected to Dominate the Market During the Forecast Period

The main factors attributing to the dominance of the hospital segment are the availability of the larger patient pool, high resource availability, high penetration in diverse geographical locations, availability of accompanying healthcare infrastructure and procedures, availability of skilled labor, and affordability via government funding. A large number of complex cardiac disease cases are on the rise, with the growth in the number of deaths due to cardiovascular diseases, across both the developed and emerging markets. The high accessibility and affordability of hospitals, as compared to the specialty clinics, attract a large patient population suffering from cardiovascular diseases. The profitability index of hospitals also increases, as they benefit from the bulk purchase discounts and trade agreements with the manufacturers and suppliers. Furthermore, these trade agreements open new avenues to timely upgradation and early access to technologically advanced products by the manufacturers, enhancing the hospital's treatment capability.

North America Dominates the Angiography Devices Market

North America dominates the angiography devices market, owing to the high adoption rate of minimally invasive procedures, availability of reimbursements, rising geriatric population, and high replacement rates of medical equipment. Factors, such as a good network of medical device companies and a large number of hospitals across cities and states with good funding opportunities, primarily help the region dominate the market. Furthermore, good support from government facilities helps in the development required for the overall treatment of cardiovascular diseases in the healthcare sector of the region.

Europe is the second-largest market after North America. The significant share of the European countries can be attributed to the high prevalence of cardiovascular diseases, high government investments, faster product approval procedures, and rising adoption of angiography devices due to a large number of angiography screening procedures being performed.

Angiography Devices Market Competitive Analysis

The angiography devices market is consolidated and highly competitive. A few global players dominate the market, primarily due to the stringent product approval process, along with the need for significant technological capabilities. The key market players include AngioDynamics Inc., Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., GE Healthcare, Medtronic PLC, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, and Terumo Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Geriatric Population and Increasing Prevalence of Cardiovascular Diseases
    • 4.2.2 Growing Demand for Interventional Angiography in Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 High Procedure and Equipment Cost
    • 4.3.2 Risks Associated with Angiography Procedures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Angiographic Systems
    • 5.1.2 Consumables
      • 5.1.2.1 Catheters
      • 5.1.2.2 Guidewires
      • 5.1.2.3 Contrast Media
      • 5.1.2.4 Incision Closure Devices
      • 5.1.2.5 Accessories
  • 5.2 By Technology
    • 5.2.1 MRI
    • 5.2.2 CT
    • 5.2.3 X-ray
    • 5.2.4 Other Technologies
  • 5.3 By Application
    • 5.3.1 Cerebral
    • 5.3.2 Carotid
    • 5.3.3 Peripheral
    • 5.3.4 Aortic
    • 5.3.5 Coronary
    • 5.3.6 Other Applications
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Diagnostic Centers
    • 5.4.3 Ambulatory Surgical Centers
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle-East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AngioDynamics Inc.
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Abbott Laboratories
    • 6.1.4 Cardinal Health Inc.
    • 6.1.5 GE Healthcare
    • 6.1.6 Medtronic PLC
    • 6.1.7 Koninklijke Philips NV
    • 6.1.8 Shimadzu Corporation
    • 6.1.9 Siemens Healthineers AG
    • 6.1.10 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS